PMID- 37998385 OWN - NLM STAT- MEDLINE DCOM- 20231130 LR - 20240201 IS - 2073-4409 (Electronic) IS - 2073-4409 (Linking) VI - 12 IP - 22 DP - 2023 Nov 18 TI - Sustained Nrf2 Overexpression-Induced Metabolic Deregulation Can Be Attenuated by Modulating Insulin/Insulin-like Growth Factor Signaling. LID - 10.3390/cells12222650 [doi] LID - 2650 AB - The modulation of insulin/insulin-like growth factor signaling (IIS) is associated with altered nutritional and metabolic states. The Drosophila genome encodes eight insulin-like peptides, whose activity is regulated by a group of secreted factors, including Ecdysone-inducible gene L2 (ImpL2), which acts as a potent IIS inhibitor. We recently reported that cncC (cncC/Nrf2), the fly ortholog of Nrf2, is a positive transcriptional regulator of ImpL2, as part of a negative feedback loop aiming to suppress cncC/Nrf2 activity. This finding correlated with our observation that sustained cncC/Nrf2 overexpression/activation (cncC(OE); a condition that signals organismal stress) deregulates IIS, causing hyperglycemia, the exhaustion of energy stores in flies' tissues, and accelerated aging. Here, we extend these studies in Drosophila by assaying the functional implication of ImpL2 in cncC(OE)-mediated metabolic deregulation. We found that ImpL2 knockdown (KD) in cncC(OE) flies partially reactivated IIS, attenuated hyperglycemia and restored tissue energetics. Moreover, ImpL2 KD largely suppressed cncC(OE)-mediated premature aging. In support, pharmacological treatment of cncC(OE) flies with Metformin, a first-line medication for type 2 diabetes, restored (dose-dependently) IIS functionality and extended cncC(OE) flies' longevity. These findings exemplify the effect of chronic stress in predisposition to diabetic phenotypes, indicating the potential prophylactic role of maintaining normal IIS functionality. FAU - Gumeni, Sentiljana AU - Gumeni S AUID- ORCID: 0000-0003-0033-2008 AD - Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15784 Athens, Greece. FAU - Lamprou, Maria AU - Lamprou M AUID- ORCID: 0000-0002-9808-5350 AD - Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15784 Athens, Greece. FAU - Evangelakou, Zoi AU - Evangelakou Z AD - Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15784 Athens, Greece. FAU - Manola, Maria S AU - Manola MS AUID- ORCID: 0000-0002-6975-2812 AD - Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15784 Athens, Greece. FAU - Trougakos, Ioannis P AU - Trougakos IP AUID- ORCID: 0000-0002-6179-2772 AD - Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15784 Athens, Greece. LA - eng GR - Tau2EpsilonDKappa-01410/MIS 5095061/European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RE-SEARCH - CREATE - INNOVATE/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20231118 PL - Switzerland TA - Cells JT - Cells JID - 101600052 RN - 0 (Drosophila Proteins) RN - 0 (ImpL2 protein, Drosophila) RN - 0 (Insulin) RN - 0 (Insulin-Like Growth Factor Binding Proteins) RN - 77469-44-4 (N,N'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) RN - 0 (NF-E2-Related Factor 2) RN - 0 (Somatomedins) RN - 0 (cnc protein, Drosophila) SB - IM MH - Animals MH - *Diabetes Mellitus, Type 2 MH - Drosophila/metabolism MH - Drosophila melanogaster/genetics MH - *Drosophila Proteins/genetics/metabolism MH - *Hyperglycemia MH - Insulin/metabolism MH - Insulin-Like Growth Factor Binding Proteins MH - NF-E2-Related Factor 2/genetics/metabolism MH - *Somatomedins/metabolism PMC - PMC10670064 OTO - NOTNLM OT - ImpL2 OT - Nrf2 OT - cncC OT - insulin/insulin-like growth factors OT - metformin COIS- The authors declare no conflict of interest. EDAT- 2023/11/24 12:42 MHDA- 2023/11/27 16:18 PMCR- 2023/11/18 CRDT- 2023/11/24 09:35 PHST- 2023/10/10 00:00 [received] PHST- 2023/11/13 00:00 [revised] PHST- 2023/11/15 00:00 [accepted] PHST- 2023/11/27 16:18 [medline] PHST- 2023/11/24 12:42 [pubmed] PHST- 2023/11/24 09:35 [entrez] PHST- 2023/11/18 00:00 [pmc-release] AID - cells12222650 [pii] AID - cells-12-02650 [pii] AID - 10.3390/cells12222650 [doi] PST - epublish SO - Cells. 2023 Nov 18;12(22):2650. doi: 10.3390/cells12222650.